This brand name is authorized in United States. It is also authorized in Canada.
The drug FIORINAL contains a combination of these active pharmaceutical ingredients (APIs):
1
|
Butalbital
UNII
KHS0AZ4JVK - BUTALBITAL
|
2
|
UNII
R16CO5Y76E - ASPIRIN
|
|
Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. |
|
3
|
UNII
3G6A5W338E - CAFFEINE
|
|
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| N02BA71 | Acetylsalicylic acid, combinations with psycholeptics | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BA Salicylic acid and derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| CA | Health Products and Food Branch | 00226327 |
| US | FDA, National Drug Code | 0023-6146 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.